End-of-day quote Bulgaria S.E. 18:00:00 2024-05-20 EDT 5-day change 1st Jan Change
4.5 BGN +2.27% Intraday chart for Etropal AD +2.27% -2.17%

Business Summary

Etropal AD is a Bulgaria-based company, which specializes in the scientific research, experimental and development activities in the field of orthopedics and traumatology. The Company manufactures and offers endoprothesys and implants, special bioceramic materials and alloys for the medicine, special surgical instruments, osteosynthesys means, single use syringes, haemodialysis apparatuses and lines and single use medical materials. The Company’s product portfolio includes fiber dialyzers, arterial and venous lines for haemodialysis, transfusion and infusion sets, fistula and injection needles, catheters, tubes, and femoral implants, among others. The Company operates through one subsidiary, Etropal Trade OOD. As of December 31, 2011, the Company’s major shareholder was Sintetika AD with a stake of 66.53%.

Number of employees: 96

Sales per Business

BGN in Million2022Weight2023Weight Delta
Products
77.7 %
4 52.0 % 8 77.7 % +140.56%
Services
9.5 %
1 10.6 % 1 9.5 % +43.72%
Goods
8.5 %
2 32.0 % 1 8.5 % -57.21%
Others
4.4 %
0 5.4 % 0 4.4 % +29.16%

Sales per region

BGN in Million2022Weight2023Weight Delta
Bulgaria
100.0 %
7 100.0 % 11 100.0 % +60.98%

Managers

Managers TitleAgeSince
Chief Executive Officer - 97-12-31
Investor Relations Contact - -
Comptroller/Controller/Auditor - -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer - 97-12-31
Director/Board Member - 06-12-31
Chairman - 14-12-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,000,000 2,449,580 ( 48.99 %) 0 48.99 %

Company contact information

Etropal AD

191 Ruski Boulevard

2180, Etropole

+359 72 06 34 22

http://www.etropal.eu
address Etropal AD(ETR)